1. Author's Information
    Yugo Tsuchiya
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

    Sew Yeu Peak-Chew
    Biological Mass Spectrometry & Proteomics Cell Biology, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, U.K.

    Clare Newell
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

    Sheritta Miller-Aidoo
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

    Sriyash Mangal
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

    Alexander Zhyvoloup
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

    Jovana Bakovic´
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

    Oksana Malanchuk
    Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv 03680, Ukraine

    Gonçalo C. Pereira
    Department of Cell and Developmental Biology, University College London, London WC1E 6BT, U.K.

    Vassilios Kotiadis
    Department of Cell and Developmental Biology, University College London, London WC1E 6BT, U.K.

    Gyorgy Szabadkai
    Department of Cell and Developmental Biology, University College London, London WC1E 6BT, U.K.

    Michael R. Duchen
    Department of Cell and Developmental Biology, University College London, London WC1E 6BT, U.K.

    Mark Campbell
    Wellcome Trust�MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, Addenbrooke`s Hospital, Cambridge CB2 OQQ, U.K.

    Sergio Rodriguez Cuenca
    Wellcome Trust�MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, Addenbrooke`s Hospital, Cambridge CB2 OQQ, U.K.

    Antonio Vidal-Puig
    Wellcome Trust�MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, Addenbrooke`s Hospital, Cambridge CB2 OQQ, U.K.

    Andrew M. James
    MRC Mitochondrial Biology Unit, Wellcome Trust, MRC Building, University of Cambridge, Cambridge CB2 0XY, U.K.

    Michael P. Murphy
    MRC Mitochondrial Biology Unit, Wellcome Trust, MRC Building, University of Cambridge, Cambridge CB2 0XY, U.K.

    Valeriy Filonenko
    Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv 03680, Ukraine

    Mark Skehel
    Biological Mass Spectrometry & Proteomics Cell Biology, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, U.K.

    Ivan Gout
    Department of Structural and Molecular Biology, University College London, London WC1E 6BT, U.K.

  2. Abstract
    Coenzyme A (CoA) is an obligatory cofactor in all branches of life. CoA and its derivatives are involved in major metabolic pathways, allosteric interactions and the regulation of gene expression. Abnormal biosynthesis and homeostasis of CoA and its derivatives have been associated with various human pathologies, including cancer, diabetes and neurodegeneration. Using an anti-CoA monoclonal antibody and mass spectrometry, we identified a wide range of cellular proteins which are modified by covalent attachment of CoA to cysteine thiols (CoAlation). We show that protein CoAlation is a reversible post-translational modification that is induced in mammalian cells and tissues by oxidising agents and metabolic stress. Many key cellular enzymes were found to be CoAlated in vitro and in vivo in ways that modified their activities. Our study reveals that protein CoAlation is a widespread post-translational modification which may play an important role in redox regulation under physiological and pathophysiological conditions.
    Keywords
    coenzyme A, metabolic and oxidative stress, post-translational modification, proteomics

    ADLID: 15947-v4
  3. Post New Comments

  1. Keywords
    coenzyme A metabolic and oxidative stress post-translational modification proteomics
Want to Index your journal in the ADL?
Suggest a Journal